Skip to main content

Table 2 EAPC of the ASIR, ASMR and ASDR of the three urologic benign diseases in global and 21 regions

From: Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019

Location EAPC of ASIR (95% CI) EAPC of ASMR (95% CI) EAPC of ASDR (95% CI)
Urinary tract infections Urolithiasis Benign prostatic hyperplasia Urinary tract infections Urolithiasis Urinary tract infections Urolithiasis Benign prostatic hyperplasia
Global 0.08 (0.04 to 0.11)  − 0.83 (− 0.92 to − 0.74)  − 0.03 (− 0.05 to − 0.01) 0.55 (0.47 to 0.62)  − 2.05 (− 2.24 to − 1.86)  − 0.08 (− 0.11 to − 0.04)  − 1.77 (− 1.91 to − 1.64)  − 0.06 (− 0.08 to − 0.03)
Andean Latin America 0.45 (0.40 to 0.50) 0.52 (0.44 to 0.59) 0.15 (0.03 to 0.28) 1.59 (1.10 to 2.08) 0.16 (− 0.04 to 0.37) 0.58 (0.18 to 0.98) 0.28 (0.19 to 0.36) 0.13 (0.01 to 0.26)
Australasia 0.09 (0.06 to 0.11)  − 0.35 (− 0.43 to − 0.26)  − 0.05 (− 0.08 to − 0.02) 0.86 (0.52 to 1.20)  − 2.15 (− 2.71 to − 1.59) 0.17 (− 0.06 to 0.39)  − 1.13 (− 1.41 to − 0.85)  − 0.04 (− 0.06 to − 0.02)
Caribbean  − 0.08 (− 0.08 to − 0.07) 0.66 (0.63 to 0.70) 0.06 (0 to 0.11) 2.45 (2.08 to 2.83) 1.60 (1.44 to 1.76) 1.91 (1.69 to 2.13) 1.08 (0.98 to 1.18) 0.02 (− 0.02 to 0.05)
Central Asia 0.03 (0.02 to 0.04) 0.05 (0.02 to 0.08) 0.09 (0.04 to 0.15) 2.56 (2.20 to 2.93) 1.74 (1.40 to 2.09) 1.70 (1.32 to 2.08) 0.29 (0.12 to 0.46) 0.05 (0.01 to 0.10)
Central Europe  − 0.28 (− 0.37 to − 0.20)  − 0.71 (− 0.99 to − 0.43)  − 0.17 (− 0.28 to − 0.07)  − 1.44 (− 2.14 to − 0.73)  − 6.31 (− 7.29 to − 5.32)  − 2.13 (− 2.75 to − 1.50)  − 3.18 (− 3.58 to − 2.78)  − 0.18 (− 0.27 to − 0.09)
Central Latin America 0.48 (0.30 to 0.66) 0.13 (− 0.2 to 0.47) 0.04 (0.01 to 0.06) 1.98 (1.68 to 2.29)  − 0.14 (− 0.37 to 0.08) 1.69 (1.37 to 2.01) 0.06 (− 0.19 to 0.31) 0 (− 0.03 to 0.02)
Central Sub-Saharan Africa 0.08 (0.07 to 0.09) 0.31 (0.25 to 0.37) 0.01 (0 to 0.02)  − 0.44 (− 0.51 to − 0.37)  − 0.78 (− 0.92 to − 0.64)  − 0.59 (− 0.67 to − 0.52)  − 0.54 (− 0.63 to − 0.45) 0.03 (0.02 to 0.04)
East Asia  − 0.19 (− 0.26 to − 0.13)  − 2.68 (− 2.95 to − 2.42)  − 0.09 (− 0.20 to 0.03)  − 1.15 (− 1.31 to − 0.98)  − 4.93 (− 5.21 to − 4.65)  − 2.35 (− 2.62 to − 2.07)  − 4.43 (− 4.68 to − 4.18)  − 0.16 (− 0.3 to − 0.02)
Eastern Europe 0.03 (0.02 to 0.04)  − 0.69 (− 0.84 to − 0.53) 0.04 (0 to 0.07)  − 0.43 (− 0.78 to − 0.08)  − 0.84 (− 1.28 to − 0.39)  − 0.86 (− 1.15 to − 0.58)  − 1.09 (− 1.35 to − 0.83) 0.03 (0.02 to 0.05)
Eastern Sub-Saharan Africa 0.09 (0.08 to 0.11) 0.15 (0.10 to 0.20) 0 (− 0.01 to 0.02)  − 0.51 (− 0.56 to − 0.45)  − 0.54 (− 0.58 to − 0.50)  − 0.91 (− 0.95 to − 0.87)  − 1.09 (− 1.16 to − 1.03) 0.02 (0.01 to 0.03)
High-income Asia Pacific  − 0.04 (− 0.10 to 0.03)  − 0.27 (− 0.35 to − 0.18)  − 0.09 (− 0.14 to − 0.03) 1.01 (0.70 to 1.32) 2.60 (2.33 to 2.87) 0.49 (0.29 to 0.69) 0.25 (0.16 to 0.33)  − 0.10 (− 0.14 to − 0.06)
High-income North America  − 0.30 (− 0.36 to − 0.25)  − 2.02 (− 2.33 to − 1.71) 0.12 (0.06 to 0.18)  − 0.08 (− 0.36 to 0.19) 0.80 (0.44 to 1.17) 0.02 (− 0.18 to 0.22)  − 1.01 (− 1.28 to − 0.73) 0.12 (0.07 to 0.17)
North Africa and Middle East 0.09 (0.08 to 0.10) 0.29 (0.25 to 0.33) 0.08 (0.07 to 0.10) 0.41 (0.13 to 0.69) 1.06 (0.66 to 1.47)  − 0.50 (− 0.69 to − 0.30) 0.20 (0.14 to 0.27) 0.07 (0.05 to 0.08)
Oceania  − 0.02 (− 0.04 to − 0.01) 0.14 (0.10 to 0.19) 0.19 (0.16 to 0.22)  − 0.43 (− 0.47 to − 0.39)  − 1.22 (− 1.32 to − 1.12)  − 0.30 (− 0.33 to − 0.26)  − 0.58 (− 0.63 to − 0.52) 0.22 (0.19 to 0.25)
South Asia 0.33 (0.30 to 0.35) 0.64 (0.50 to 0.78) 0.30 (0.15 to 0.44)  − 0.16 (− 0.29 to − 0.04)  − 2.65 (− 2.81 to − 2.49)  − 0.49 (− 0.56 to − 0.42)  − 1.20 (− 1.35 to − 1.05) 0.37 (0.22 to 0.52)
Southeast Asia  − 0.20 (− 0.26 to − 0.13)  − 0.82 (− 0.94 to − 0.69)  − 0.09 (− 0.19 to 0.01)  − 0.19 (− 0.29 to − 0.09)  − 0.88 (− 1.01 to − 0.75)  − 0.64 (− 0.73 to − 0.55)  − 1.15 (− 1.24 to − 1.07)  − 0.14 (− 0.26 to − 0.02)
Southern Latin America 0.12 (0.04 to 0.19)  − 0.21 (− 0.28 to − 0.14) 0.07 (0.02 to 0.11) 4.92 (4.29 to 5.56) 1.13 (0.74 to 1.52) 4.12 (3.6 to 4.64)  − 0.07 (− 0.16 to 0.02) 0.07 (0.04 to 0.09)
Southern Sub-Saharan Africa 0.01 (− 0.01 to 0.03) 0.11 (0.07 to 0.15) 0.12 (0.09 to 0.15)  − 0.08 (− 0.67 to 0.50)  − 0.17 (− 0.83 to 0.49)  − 0.39 (− 1.05 to 0.28)  − 0.22 (− 0.58 to 0.13) 0.12 (0.09 to 0.15)
Tropical Latin America 0.03 (− 0.04 to 0.11)  − 0.36 (− 0.44 to − 0.28)  − 0.03 (− 0.09 to 0.03) 3.50 (3.15 to 3.85) 4.00 (3.76 to 4.24) 2.28 (1.99 to 2.56) 2.07 (1.94 to 2.20)  − 0.05 (− 0.10 to 0.01)
Western Europe  − 0.28 (− 0.40 to − 0.15) 0.53 (0.38 to 0.68)  − 0.03 (− 0.11 to 0.04) 2.19 (1.83 to 2.54)  − 1.11 (− 1.55 to − 0.68) 1.38 (1.12 to 1.65)  − 0.03 (− 0.20 to 0.14)  − 0.08 (− 0.11 to − 0.06)
Western Sub-Saharan Africa 0.16 (0.15 to 0.17) 0.28 (0.23 to 0.33) 0.03 (0.02 to 0.04)  − 0.93 (− 1.02 to − 0.84)  − 1.29 (− 1.39 to − 1.20)  − 1.02 (− 1.11 to − 0.93)  − 0.45 (− 0.48 to − 0.42) 0.04 (0.03 to 0.05)
  1. EAPC estimated annual percentage change; ASIR age-standardized incidence rate; ASMR age-standardized mortality rate; ASDR age-standardized DALYs rate; CI confidence interval